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1. Introduction 
Prolyl hydroxylase, a key enzyme of collagen 
biosynthesis, catalyses the hydroxylation of peptide- 
bound proline to hydroxy proline in a polypeptide 
precursor of collagen [l] . It is consistently found in 
connective tissue cells and in smaller amounts in 
certain non-fibroblastic cells, e.g., liver parenchyma, 
epithelium, melanoma, pituitary, kidney and neuro- 
blastoma, several of which also synthesize collagen 
po~ypeptide 12-6). Certain plant cell wall proteins 
contain hydroxyproline, and prolyl hydroxylase has 
been found in carrot discs [7]. 
Human blood serum contains small amounts of the 
enzyme ]8,9] but little is known about its occurrence 
in the formed elements of the blood. Green and 
Goldberg found significant amounts in certain cultured 
lymphoma lines, which also contained traces of collagen 
polypep tide [ 2,3] . 
In view of the marked response of prolyl hydro- 
xylase to vitamin C deficiency in cultured 3T6 fibro- 
blasts [lo] , an approach to the detection of the early 
stages of functional vitamin C deficiency in animals 
and humans prompted an examination of blood-borne 
cells for this enzyme. 
2. Materials and methods 
2.1. separation of enzyme extracts from blood cells 
and liver tissue 
About 30-60 ml blood from adult rats or from a 
human donor were anticoagulated with about 0.1 vol. 
0.55 M sodium citrate, pH 7.4 and were layered in 3 ml 
aliquots over an equal volume of a blood separation 
mixture, density 1075, containing Triosil440 (metri- 
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zoate radiographic contrast media from Nyegaard and 
Co., Oslo) and methyl cellulose [ 111. After standing 
for 0.5- 1 .O h, the upper layers containing the leuco- 
cytes and platelets were removed by suction and were 
centrifuged at 330 X g for 10 min; this sedimented 
virtually all the leucocytes and erythrocytes, leaving 
the platelets in suspension. The leucocyte-rich pellet 
was suspended in 0.87% ammonium chloride for 
10 min to lyse the contanlinating erythrocytes [ 121 
and washed with buffered saline. Microscopic exami- 
nation and differential counting in a Coulter Counter, 
model Zn,, confirmed that platelets were virtually 
absent from the final leucocyte preparation and that 
leucocytes were virtually absent from the platelet-rich 
plasma. The platelets were collected by centrifugation 
of the platelet-rich plasma at 2400 X g for 20 min and 
washed with buffered saline. Erythrocytes were obtain- 
ed from the lower layers of the blood separation mix- 
tures, and washed several times with buffered saline. 
Extracts for prolyl hydroxylase assay were prepared 
by gentle homogenisation, in a Potter-Elvehjem 
homogeniser, of the various blood cell fractions in a 
solution, pH 7.4, containing 0.2% Nonidet P-40 (a 
nonionic surfactant), 0.1 mM dithiothreitol, and 0.05 M 
Tris-chloride, followed by centrifugation at 2400 X g 
for 20 min to remove the insoluble residue. The 
leucocytes were homogenised in 0.5-l .O ml of this 
buffer, yielding 2-5 mg soluble protein per ml; the 
platelets were homogenised in 1 .O-2.0 ml, yielding 
8-20 mg soluble protein per ml. The erythrocytes 
were homogenised in 9 vols of buffer yielding about 
50 mg soluble protein per ml; samples of pooled rat 
liver were homogenised in 9 vols of buffer per gram 
wet weight, yielding about 20 mg soluble protein 
per ml. Protein was measured by the Folin method 
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2.2. Assay of prolyl hydroxylase in extracts Table 2 
Cofactor-dependence of platelet prolyl hydroxylase 
_ 
Prolyl hydroxylase activity was measured by the 
release of 3Hz0 from underhydroxylated chick 
embryo substrate [ 141. Although the batch of sub- 
strate used apparently had rather a low specific activity 
in terms of hydroxylatable proline residues, it also 
yielded low blank values and was adequate for the 
purposes of this investigation. Use of a more sensitive 
substrate would, of course, increase the sensitivity of 
the assay and permit the use of smaller amounts of 
enzyme extract. 
Cofactor omission 
None (all cofactors present) 
Minus cu-ketoglutaric acid 
Minus ascorbic acid 
Minus ferrous iron 
Activity relative to control 
100 
<2 
12 
20 
0.3-0.5 ml Enzyme extract was incubated at 35’C 
for 60 min in 1 .O ml of a solution, pH 7.4, containing 
substrate (3.0 mg protein, 56 000 dpm), 0.1 M Tris- 
chloride, 0.012 M L-ascorbic acid, 0.001 M ferrous 
ammonium sulphate, 0.002 M a-ketoglutaric acid and 
1800 units Sigma grade C-l 00 catalase. The reaction 
was stopped with 0.05 ml 100% w/v trichloroacetic 
acid, 3HZ0 was distilled at about 60°C and was mea- 
sured by scintillation counting at 34% efficiency. 
Blank values were obtained by incubation of substrate 
plus cofactors and buffer, but without enzyme. 
tion, mainly because of the difficulty of obtaining 
pure leucocytes in sufficient numbers to give a concen- 
trated extract. Plasma was inactive, but this was pro- 
bably due to the presence of citrate, which is known 
to be inhibitory [8]. 
All of the prolyl hydroxylase in the platelet extracts 
was soluble in the extraction medium; none could be 
detected in the insoluble residue after washing. Activity 
increased linearly with time up to 60 min and was 
absolutely dependent on added a-ketoglutaric acid; 
ascorbic acid and ferrous iron were also stimulatory 
(table 2). 
3. Results 
Of the fractions from rat blood, only the platelet 
extract consistently yielded significant prolyl hydroxy- 
lase activity (table 1). Its specific activity was about 
one fifth of that of rat liver extracts prepared under 
similar conditions; several further experiments verified 
this result. Erythrocytes yielded no measurable activity; 
variable results were obtained with the leucocyte frac- 
Human blood yielded a similar picture: the platelet 
fraction alone contained measurable enzyme, whose 
specific activity was similar to that of the rat platelet 
extract. The leucocyte fraction, which was easier to 
prepare in a pure and concentrated form than that 
from rat blood, had less than 5% of the specific activity 
of the platelet extract. Addition of human leucocyte 
extract to rat liver extract failed to inhibit the 
enzyme present in the liver extract. 
4. Discussion 
Table 1 
Comparison of prolyl hydroxylase activities in extracts of 
rat blood fractions and of rat liver 
Enzyme extract Prolyl hydroxylase activity 
(dpm/min/mg protein/h incubation) 
_ 
Experiment 1 Experiment 2 
Rat liver 162 71 
Rat plasma <0.15 _ 
Rat erythrocytes _ <0.15 
Rat platelets 29 18 
Preparation of enzyme extracts and the conditions of assay 
are described under Materials and methods. 
The failure of the human leucocyte extract to 
catalyse hydroxylation was not, apparently, an arti- 
fact due to destruction of substrate by collagenolytic 
activity [ 151 or to inhibition by free radical or 
peroxidegenerating reactions [ 161 because the rat 
liver enzyme worked normally in its presence. It seems 
improbable that contaminating connective tissue cell, 
or fragments of them, could have been the source of 
the enzyme in the platelet fraction: those platelet 
samples which appeared entirely homogeneous under 
the microscope had specific activities at least as high 
as preparations which were obviously slightly con- 
taminated with other cell types. Stein et al. [8] noted 
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that more prolyl hydroxylase could be detected in 
serum than in plasma; this difference might be attri- 
butable to release of the enzyme from platelets 
during clotting. 
Platelets have recently been shown to possess the 
two glycosylating enzymes which add galactose, then 
glucose, to the hydroxylysyl residues of collagen 
[17-l 91 - they may, therefore, contain several 
components of the machinery of collagen synthesis. 
The possibility that platelets could in fact be capable 
of collagen synthesis under certain conditions in vivo 
has obvious relevance to wound healing and the 
fibrotic reactions associated with arterial disease. 
If any of the platelet prolyl hydroxylase were 
present on the surface membranes of the cells, it 
might also play a role in collagen-induced platelet 
aggregation, since normal collagen contains some 
potentially hydroxylatable prolyl residues [20,21]. 
It is unlikely that this could constitute a major inter- 
action site however, because hydroxylation requires 
single collagen chains [22,23], whereas platelet inter- 
action favours triple helical, fibrillar collagen [24-261. 
From a purely practical viewpoint the presence 
of prolyl hydroxylase in platelets might be a useful 
tool to investigate the physiological control and patho- 
logical responses of this key enzyme, since platelets 
are a convenient biopsy tissue for studies on human 
subjects. 
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